Clinical Trial Results

Showing: All studies [change]
Condition: Lupus 25 trials found
New Search
Filter
Trial Phase
Study Type
Wellness & Workforce Solution for Lupus/Lupus Nephritis
NAINTERVENTIONAL Atlanta, Georgia +4 more
RECRUITING
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
PHASE3INTERVENTIONAL Chandler, Arizona +4 more
RECRUITING
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
PHASE1INTERVENTIONAL Anniston, Alabama +4 more
RECRUITING
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
PHASE3INTERVENTIONAL Los Angeles, California +4 more
RECRUITING
A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
PHASE3INTERVENTIONAL Anniston, Alabama +4 more
RECRUITING
A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
PHASE1INTERVENTIONAL Redwood City, California +4 more
RECRUITING
Achievement of LLDAS5 in Patients With Systemic Lupus Erythematosus Treated With Anifrolumab.
N/AOBSERVATIONAL Monserrato, CA +4 more
RECRUITING
Childhood-onset Lupus Nephritis Initial Glucocorticoid-dose Harmonization Trial (LIGHT Trial)
PHASE4INTERVENTIONAL Beijing, Beijing Municipality +4 more
RECRUITING
Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in Anifrolumab Users
PHASE4INTERVENTIONAL Las Vegas, Nevada +4 more
RECRUITING
A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
N/AOBSERVATIONAL Mesa, Arizona +4 more
RECRUITING
Creating Health Course Study for People With Rheumatological Conditions and Mood Disorders
NAINTERVENTIONAL Iowa City, Iowa +4 more
RECRUITING
Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases
PHASE4INTERVENTIONAL São Paulo, São Paulo +4 more
RECRUITING
Phase 1a/b Tolerability of NTR-1011 in Healthy Adults and Adult Patients With SLE and RA
PHASE1INTERVENTIONAL Apple Valley, California +4 more
RECRUITING
Effect of Anti-inflammatory Diet in Systemic Lupus Erythematous
NAINTERVENTIONAL La Jolla, California +4 more
RECRUITING
The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE) - IFN-CVD
PHASE2INTERVENTIONAL Bethesda, Maryland +4 more
RECRUITING
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
PHASE3INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
INTERSTELLAR - International Study Evaluating Lupus Outcomes After Anifrolumab Real World Use
N/AOBSERVATIONAL Guangzhou +4 more
RECRUITING
A Study of LY4298445 in Healthy Participants and Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
PHASE1INTERVENTIONAL Brisbane +4 more
RECRUITING
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)
PHASE3INTERVENTIONAL Upland, California +4 more
RECRUITING
A Study of Intravenous CPTX2309 in Healthy Participants and Participants With Moderate to Severe Rheumatoid Arthritis (RA) or Systemic Lupus Erythematosus (SLE)
PHASE1INTERVENTIONAL Herston, Queensland +4 more
RECRUITING
The Efficacy of Empagliflozin on Kidney Functions in Lupus Nephritis Population
PHASE4INTERVENTIONAL Banī Suwayf +4 more
RECRUITING
Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)
PHASE3INTERVENTIONAL Salvador, Estado de Bahia +4 more
RECRUITING
A Study of GNC-038 Tetra-specific Antibody Injection in Patients With Systemic Lupus Erythematosus
PHASE1INTERVENTIONAL Shanghai, Shanghai Municipality +4 more
RECRUITING
Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis
PHASE1INTERVENTIONAL Rochester, Minnesota +4 more
RECRUITING
CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
PHASE1INTERVENTIONAL Hanoi +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type